Mirae Asset Global ETFs Holdings
CDTX

Mirae Asset Global ETFs Holdings’s Cidara Therapeutics CDTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,614
Closed -$2.34M – 3130
2025
Q4 		$2.34M Buy
10,614
+1,820
+21% +$294K ﹤0.01% 1085
2025
Q3 		$841K Sell
8,794
-420
-5% -$26.8K ﹤0.01% 1587
2025
Q2 		$449K Buy
+9,214
New +$221K ﹤0.01% 1870

Mirae Asset Global ETFs Holdings's CDTX Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 10,614 shares — an estimated $2.34M sold.

Mirae Asset Global ETFs Holdings first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $2.34M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

  • Mirae Asset Global ETFs Holdings reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 10,614 Cidara Therapeutics shares in Q1 2026, an estimated $2.34M.
  • Mirae Asset Global ETFs Holdings first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Cidara Therapeutics position peaked at $2.34M in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.